Kymera Therapeutics Inc
KYMR
Equity
ISIN null / Valor 56388008
NASDAQ (2026-07-06)
USD 114.76+1.10%
Kymera Therapeutics Inc
UMushroom community rating:
About company
Kymera Therapeutics Inc. is a biopharmaceutical company focused on developing targeted protein degradation therapies.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
156%1Y
418%3Y
111%5Y
Performance
56.8%1Y
67.1%3Y
71.7%5Y
Volatility
9440 M
Market cap (USD)
625,153
Daily traded volume (Shares)
39.69 / 38.29
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
